Published in Infect Immun on June 01, 2003
Immunoglobulin responses at the mucosal interface. Annu Rev Immunol (2011) 1.82
Genome analysis of Moraxella catarrhalis strain BBH18, [corrected] a human respiratory tract pathogen. J Bacteriol (2010) 1.57
The Moraxella catarrhalis porin-like outer membrane protein CD is an adhesin for human lung cells. Infect Immun (2004) 1.30
The Hag protein of Moraxella catarrhalis strain O35E is associated with adherence to human lung and middle ear cells. Infect Immun (2003) 1.26
Molecular aspects of Moraxella catarrhalis pathogenesis. Microbiol Mol Biol Rev (2009) 1.19
Biofilm formation by Moraxella catarrhalis in vitro: roles of the UspA1 adhesin and the Hag hemagglutinin. Infect Immun (2006) 1.12
B cell activation by outer membrane vesicles--a novel virulence mechanism. PLoS Pathog (2010) 1.09
Moraxella catarrhalis strain O35E expresses two filamentous hemagglutinin-like proteins that mediate adherence to human epithelial cells. Infect Immun (2007) 1.07
Moraxella catarrhalis outer membrane vesicles carry β-lactamase and promote survival of Streptococcus pneumoniae and Haemophilus influenzae by inactivating amoxicillin. Antimicrob Agents Chemother (2011) 1.05
Roles of 3-deoxy-D-manno-2-octulosonic acid transferase from Moraxella catarrhalis in lipooligosaccharide biosynthesis and virulence. Infect Immun (2005) 0.98
Hag directly mediates the adherence of Moraxella catarrhalis to human middle ear cells. Infect Immun (2005) 0.98
Characterization of a cluster of three glycosyltransferase enzymes essential for Moraxella catarrhalis lipooligosaccharide assembly. J Bacteriol (2005) 0.97
Regions important for the adhesin activity of Moraxella catarrhalis Hag. BMC Microbiol (2007) 0.92
Identification of a repressor of a truncated denitrification pathway in Moraxella catarrhalis. J Bacteriol (2008) 0.91
Synthesis and characterization of lipooligosaccharide-based conjugate vaccines for serotype B Moraxella catarrhalis. Infect Immun (2005) 0.89
Moraxella catarrhalis outer membrane protein CD elicits antibodies that inhibit CD binding to human mucin and enhance pulmonary clearance of M. catarrhalis in a mouse model. Infect Immun (2007) 0.89
Biological and immunological characteristics of lipooligosaccharide-based conjugate vaccines for serotype C Moraxella catarrhalis. Infect Immun (2007) 0.88
Characterization of the molecular interplay between Moraxella catarrhalis and human respiratory tract epithelial cells. PLoS One (2013) 0.87
Comparison of the serological responses to Moraxella catarrhalis immunoglobulin D-binding outer membrane protein and the ubiquitous surface proteins A1 and A2. Infect Immun (2006) 0.87
Hag mediates adherence of Moraxella catarrhalis to ciliated human airway cells. Infect Immun (2009) 0.86
Modular arrangement of allelic variants explains the divergence in Moraxella catarrhalis UspA protein function. Infect Immun (2008) 0.86
The Moraxella catarrhalis nitric oxide reductase is essential for nitric oxide detoxification. J Bacteriol (2011) 0.86
Identification of a bacteriocin and its cognate immunity factor expressed by Moraxella catarrhalis. BMC Microbiol (2009) 0.85
Identification of domains of the Hag/MID surface protein recognized by systemic and mucosal antibodies in adults with chronic obstructive pulmonary disease following clearance of Moraxella catarrhalis. Clin Vaccine Immunol (2009) 0.85
Vaccine targets against Moraxella catarrhalis. Expert Opin Ther Targets (2015) 0.84
Multiplex PCR assay that identifies the major lipooligosaccharide serotype expressed by Moraxella catarrhalis clinical isolates. J Clin Microbiol (2005) 0.84
Comprehensive antigen screening identifies Moraxella catarrhalis proteins that induce protection in a mouse pulmonary clearance model. PLoS One (2013) 0.83
Regulation of frontline antibody responses by innate immune signals. Immunol Res (2012) 0.81
Use of the chinchilla model for nasopharyngeal colonization to study gene expression by Moraxella catarrhalis. Infect Immun (2011) 0.81
Galactose residues on the lipooligosaccharide of Moraxella catarrhalis 26404 form the epitope recognized by the bactericidal antiserum from conjugate vaccination. Infect Immun (2008) 0.80
A UspA2H-negative variant of Moraxella catarrhalis strain O46E has a deletion in a homopolymeric nucleotide repeat common to uspA2H genes. Infect Immun (2007) 0.79
Identification of an outer membrane lipoprotein involved in nasopharyngeal colonization by Moraxella catarrhalis in an animal model. Infect Immun (2014) 0.76
Adhesion of Moraxella catarrhalis to human bronchial epithelium characterized by a novel fluorescence-based assay. Med Microbiol Immunol (2005) 0.76
A Moraxella catarrhalis two-component signal transduction system necessary for growth in liquid media affects production of two lysozyme inhibitors. Infect Immun (2014) 0.75
THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. Biochem J (1963) 61.56
Prediction and analysis of coiled-coil structures. Methods Enzymol (1996) 5.74
Structure and sequence analysis of Yersinia YadA and Moraxella UspAs reveal a novel class of adhesins. EMBO J (2000) 3.23
Branhamella catarrhalis: an organism gaining respect as a pathogen. Clin Microbiol Rev (1990) 2.43
The UspA1 protein and a second type of UspA2 protein mediate adherence of Moraxella catarrhalis to human epithelial cells in vitro. J Bacteriol (2000) 2.10
Phenotypic effect of isogenic uspA1 and uspA2 mutations on Moraxella catarrhalis 035E. Infect Immun (1998) 2.03
Moraxella catarrhalis: a review of an important human mucosal pathogen. Microbes Infect (2000) 1.94
Characterization of the Moraxella catarrhalis uspA1 and uspA2 genes and their encoded products. J Bacteriol (1999) 1.82
A large, antigenically conserved protein on the surface of Moraxella catarrhalis is a target for protective antibodies. J Infect Dis (1994) 1.62
Purification and characterization of a high-molecular-weight outer membrane protein of Moraxella (Branhamella) catarrhalis. Infect Immun (1994) 1.52
A hag mutant of Moraxella catarrhalis strain O35E is deficient in hemagglutination, autoagglutination, and immunoglobulin D-binding activities. Infect Immun (2002) 1.35
Many bacterial species bind human IgD. J Immunol (1979) 1.34
The Moraxella catarrhalis immunoglobulin D-binding protein MID has conserved sequences and is regulated by a mechanism corresponding to phase variation. J Bacteriol (2003) 1.28
Expression of the Moraxella catarrhalis UspA1 protein undergoes phase variation and is regulated at the transcriptional level. J Bacteriol (2001) 1.26
Analysis of Moraxella catarrhalis by DNA typing: evidence for a distinct subpopulation associated with virulence traits. J Infect Dis (2000) 1.22
Isolation and characterization of a novel IgD-binding protein from Moraxella catarrhalis. J Immunol (2001) 1.13
Vaccines for Moraxella catarrhalis. Vaccine (2000) 1.13
The outer membrane proteins UspA1 and UspA2 of Moraxella catarrhalis are highly conserved in nasopharyngeal isolates from young children. Vaccine (2002) 1.10
The novel IgD binding protein from Moraxella catarrhalis induces human B lymphocyte activation and Ig secretion in the presence of Th2 cytokines. J Immunol (2002) 1.00
The immunoglobulin D-binding part of the outer membrane protein MID from Moraxella catarrhalis comprises 238 amino acids and a tetrameric structure. J Biol Chem (2002) 0.98
A 200 kDa protein is associated with haemagglutinating isolates of Moraxella (Branhamella) catarrhalis. FEMS Immunol Med Microbiol (1997) 0.95
Branhamella catarrhalis activates human B lymphocytes following interactions with surface IgD and class I major histocompatibility complex antigens. Cell Immunol (1988) 0.94
Tissue culture adherence and haemagglutination characteristics of Moraxella (Branhamella) catarrhalis. FEMS Immunol Med Microbiol (1999) 0.89
Characteristics of human B cells responsive to the T-independent mitogen Branhamella catarrhalis. Immunology (1986) 0.82
Immunoglobulin D enhances immune surveillance by activating antimicrobial, proinflammatory and B cell-stimulating programs in basophils. Nat Immunol (2009) 1.97
Complement evasion strategies of pathogens-acquisition of inhibitors and beyond. Mol Immunol (2009) 1.73
Effects of NOD-like receptors in human B lymphocytes and crosstalk between NOD1/NOD2 and Toll-like receptors. J Leukoc Biol (2010) 1.62
Genome analysis of Moraxella catarrhalis strain BBH18, [corrected] a human respiratory tract pathogen. J Bacteriol (2010) 1.57
Biphasic effect of gingipains from Porphyromonas gingivalis on the human complement system. J Immunol (2007) 1.50
Wnt-5a mRNA translation is suppressed by the Elav-like protein HuR in human breast epithelial cells. Nucleic Acids Res (2006) 1.43
Streptococcal M protein: a multipotent and powerful inducer of inflammation. J Immunol (2006) 1.36
Vitronectin in bacterial pathogenesis: a host protein used in complement escape and cellular invasion. Mol Microbiol (2010) 1.34
The emerging pathogen Moraxella catarrhalis interacts with complement inhibitor C4b binding protein through ubiquitous surface proteins A1 and A2. J Immunol (2004) 1.32
The Moraxella catarrhalis immunoglobulin D-binding protein MID has conserved sequences and is regulated by a mechanism corresponding to phase variation. J Bacteriol (2003) 1.28
Protein D of Haemophilus influenzae: a protective nontypeable H. influenzae antigen and a carrier for pneumococcal conjugate vaccines. Clin Infect Dis (2008) 1.26
CEACAM1 inhibits Toll-like receptor 2-triggered antibacterial responses of human pulmonary epithelial cells. Nat Immunol (2008) 1.26
Human pathogens utilize host extracellular matrix proteins laminin and collagen for adhesion and invasion of the host. FEMS Microbiol Rev (2012) 1.19
Clinical isolates of Streptococcus pneumoniae bind the complement inhibitor C4b-binding protein in a PspC allele-dependent fashion. J Immunol (2009) 1.18
Nontypeable Haemophilus influenzae protein E binds vitronectin and is important for serum resistance. J Immunol (2009) 1.17
Interpain A, a cysteine proteinase from Prevotella intermedia, inhibits complement by degrading complement factor C3. PLoS Pathog (2009) 1.16
Binding of complement inhibitor C4b-binding protein contributes to serum resistance of Porphyromonas gingivalis. J Immunol (2008) 1.14
A novel localization of the G-protein-coupled CysLT1 receptor in the nucleus of colorectal adenocarcinoma cells. Cancer Res (2005) 1.13
B cell activation by outer membrane vesicles--a novel virulence mechanism. PLoS Pathog (2010) 1.09
Haemophilus influenzae survival during complement-mediated attacks is promoted by Moraxella catarrhalis outer membrane vesicles. J Infect Dis (2007) 1.08
A metalloproteinase karilysin present in the majority of Tannerella forsythia isolates inhibits all pathways of the complement system. J Immunol (2012) 1.07
Human complement control and complement evasion by pathogenic microbes--tipping the balance. Mol Immunol (2013) 1.05
Moraxella catarrhalis outer membrane vesicles carry β-lactamase and promote survival of Streptococcus pneumoniae and Haemophilus influenzae by inactivating amoxicillin. Antimicrob Agents Chemother (2011) 1.05
Bacterial outer membrane vesicles in disease and preventive medicine. Semin Immunopathol (2010) 1.05
Haemophilus influenzae surface fibrils contribute to serum resistance by interacting with vitronectin. J Immunol (2006) 1.04
Haemophilus influenzae and the complement system. Trends Microbiol (2010) 1.03
Enolase of Streptococcus pneumoniae binds human complement inhibitor C4b-binding protein and contributes to complement evasion. J Immunol (2012) 1.02
The respiratory pathogen Moraxella catarrhalis adheres to epithelial cells by interacting with fibronectin through ubiquitous surface proteins A1 and A2. J Infect Dis (2005) 1.02
The choline-binding protein PspC of Streptococcus pneumoniae interacts with the C-terminal heparin-binding domain of vitronectin. J Biol Chem (2013) 1.01
The respiratory pathogen moraxella catarrhalis binds to laminin via ubiquitous surface proteins A1 and A2. J Infect Dis (2006) 1.01
Multicomponent Moraxella catarrhalis outer membrane vesicles induce an inflammatory response and are internalized by human epithelial cells. Cell Microbiol (2010) 1.01
The novel IgD binding protein from Moraxella catarrhalis induces human B lymphocyte activation and Ig secretion in the presence of Th2 cytokines. J Immunol (2002) 1.00
Haemophilus influenzae uses the surface protein E to acquire human plasminogen and to evade innate immunity. J Immunol (2011) 0.99
Interaction with C4b-binding protein contributes to nontypeable Haemophilus influenzae serum resistance. J Immunol (2007) 0.99
The immunoglobulin D-binding part of the outer membrane protein MID from Moraxella catarrhalis comprises 238 amino acids and a tetrameric structure. J Biol Chem (2002) 0.98
Haemophilus influenzae protein E recognizes the C-terminal domain of vitronectin and modulates the membrane attack complex. Mol Microbiol (2011) 0.98
Streptococcus pneumoniae endopeptidase O (PepO) is a multifunctional plasminogen- and fibronectin-binding protein, facilitating evasion of innate immunity and invasion of host cells. J Biol Chem (2013) 0.98
The activation pattern of blood leukocytes in head and neck squamous cell carcinoma is correlated to survival. PLoS One (2012) 0.98
Ionic binding of C3 to the human pathogen Moraxella catarrhalis is a unique mechanism for combating innate immunity. J Immunol (2005) 0.97
Immunization with the truncated adhesin moraxella catarrhalis immunoglobulin D-binding protein (MID764-913) is protective against M. catarrhalis in a mouse model of pulmonary clearance. J Infect Dis (2004) 0.96
Haemophilus influenzae acquires vitronectin via the ubiquitous Protein F to subvert host innate immunity. Mol Microbiol (2013) 0.96
Increase of β-lactam-resistant invasive Haemophilus influenzae in Sweden, 1997 to 2010. Antimicrob Agents Chemother (2012) 0.95
Haemophilus influenzae interacts with the human complement inhibitor factor H. J Immunol (2008) 0.95
Vitronectin binds to the head region of Moraxella catarrhalis ubiquitous surface protein A2 and confers complement-inhibitory activity. Mol Microbiol (2010) 0.94
Haemophilus influenzae protein E binds to the extracellular matrix by concurrently interacting with laminin and vitronectin. J Infect Dis (2011) 0.93
Nucleotide-binding and oligomerization domain-like receptors and retinoic acid inducible gene-like receptors in human tonsillar T lymphocytes. Immunology (2011) 0.92
Toll-like receptor agonists induce inflammation and cell death in a model of head and neck squamous cell carcinomas. Immunology (2008) 0.92
High incidence of septic shock caused by Streptococcus pneumoniae serotype 3--a retrospective epidemiological study. BMC Infect Dis (2013) 0.92
CTLA4Ig combined with anti-LFA-1 prolongs cardiac allograft survival indefinitely. Transpl Immunol (2002) 0.91
Several gene programs are induced in ciprofloxacin-treated human lymphocytes as revealed by microarray analysis. J Leukoc Biol (2003) 0.90
Protein E of Haemophilus influenzae is a ubiquitous highly conserved adhesin. J Infect Dis (2010) 0.89
Nontypeable Haemophilus influenzae adhesin protein E: characterization and biological activity. J Infect Dis (2009) 0.89
Haemophilus influenzae: recent advances in the understanding of molecular pathogenesis and polymicrobial infections. Curr Opin Infect Dis (2014) 0.89
The unique structure of Haemophilus influenzae protein E reveals multiple binding sites for host factors. Infect Immun (2012) 0.89
The IgD-binding domain of the Moraxella IgD-binding protein MID (MID962-1200) activates human B cells in the presence of T cell cytokines. J Leukoc Biol (2005) 0.89
The UspA1 protein of Moraxella catarrhalis induces CEACAM-1-dependent apoptosis in alveolar epithelial cells. J Infect Dis (2007) 0.88
Comparative study of immune status to infectious agents in elderly patients with multiple myeloma, Waldenstrom's macroglobulinemia, and monoclonal gammopathy of undetermined significance. Clin Vaccine Immunol (2011) 0.88
Group A streptococci are protected from amoxicillin-mediated killing by vesicles containing β-lactamase derived from Haemophilus influenzae. J Antimicrob Chemother (2013) 0.87
Comparison of the antibacterial activities of ampicillin, ciprofloxacin, clarithromycin, telithromycin and quinupristin/dalfopristin against intracellular non-typeable Haemophilus influenzae. J Antimicrob Chemother (2002) 0.87
Comparison of the serological responses to Moraxella catarrhalis immunoglobulin D-binding outer membrane protein and the ubiquitous surface proteins A1 and A2. Infect Immun (2006) 0.87
Moraxella catarrhalis: from interactions with the host immune system to vaccine development. Future Microbiol (2012) 0.87
A fine-tuned interaction between trimeric autotransporter haemophilus surface fibrils and vitronectin leads to serum resistance and adherence to respiratory epithelial cells. Infect Immun (2014) 0.86
Binding of complement regulators to invasive nontypeable Haemophilus influenzae isolates is not increased compared to nasopharyngeal isolates, but serum resistance is linked to disease severity. J Clin Microbiol (2010) 0.86
Susceptibilities of Mycobacterium marinum to gatifloxacin, gemifloxacin, levofloxacin, linezolid, moxifloxacin, telithromycin, and quinupristin-dalfopristin (Synercid) compared to its susceptibilities to reference macrolides and quinolones. Antimicrob Agents Chemother (2002) 0.86
Nontypeable Haemophilus influenzae activates human eosinophils through beta-glucan receptors. Am J Respir Cell Mol Biol (2003) 0.86
Current progress of adhesins as vaccine candidates for Moraxella catarrhalis. Expert Rev Vaccines (2007) 0.86
Immune evasion of Moraxella catarrhalis involves ubiquitous surface protein A-dependent C3d binding. J Immunol (2011) 0.86
QseC controls biofilm formation of non-typeable Haemophilus influenzae in addition to an AI-2-dependent mechanism. Int J Med Microbiol (2012) 0.85
Virulence mechanisms of Moraxella in the pathogenesis of infection. Curr Opin Infect Dis (2009) 0.85
Necrotizing myositis and septic shock caused by Haemophilus influenzae type f in a previously healthy man diagnosed with an IgG3 and a mannose-binding lectin deficiency. Scand J Infect Dis (2011) 0.85
Identification of a novel Haemophilus influenzae protein important for adhesion to epithelial cells. Microbes Infect (2007) 0.84
Superantigen- and TLR-dependent activation of tonsillar B cells after receptor-mediated endocytosis. J Immunol (2009) 0.84
Alpha1-antitrypsin inhibits Moraxella catarrhalis MID protein-induced tonsillar B cell proliferation and IL-6 release. Immunol Lett (2005) 0.84
Moraxella catarrhalis-dependent tonsillar B cell activation does not lead to apoptosis but to vigorous proliferation resulting in nonspecific IgM production. J Leukoc Biol (2008) 0.83
Haemophilus influenzae protein F mediates binding to laminin and human pulmonary epithelial cells. J Infect Dis (2012) 0.83
Outer membrane vesicles shield Moraxella catarrhalis β-lactamase from neutralization by serum IgG. J Antimicrob Chemother (2012) 0.83
Impact of sequence diversity in the Moraxella catarrhalis UspA2/UspA2H head domain on vitronectin binding and antigenic variation. Microbes Infect (2013) 0.82
Binding of vitronectin and Factor H to Hic contributes to immune evasion of Streptococcus pneumoniae serotype 3. Thromb Haemost (2014) 0.82
A pilot with pain in his leg: thigh abscess caused by Salmonella enterica serotype Brandenburg. J Clin Microbiol (2002) 0.81
An alternative role of C1q in bacterial infections: facilitating Streptococcus pneumoniae adherence and invasion of host cells. J Immunol (2013) 0.81
Dicloxacillin and erythromycin at high concentrations increase ICAM-1 expression by endothelial cells: a possible factor in the pathogenesis of infusion phlebitis. J Antimicrob Chemother (2004) 0.81
Temporal development of the humoral immune response to surface antigens of Moraxella catarrhalis in young infants. Vaccine (2011) 0.81
The Moraxella IgD-binding protein MID/Hag is an oligomeric autotransporter. Microbes Infect (2008) 0.80
Acquisition of complement inhibitor serine protease factor I and its cofactors C4b-binding protein and factor H by Prevotella intermedia. PLoS One (2012) 0.80
Haemophilus influenzae resides in tonsils and uses immunoglobulin D binding as an evasion strategy. J Infect Dis (2013) 0.80
Comparative analysis of the humoral immune response to Moraxella catarrhalis and Streptococcus pneumoniae surface antigens in children suffering from recurrent acute otitis media and chronic otitis media with effusion. Clin Vaccine Immunol (2012) 0.79
Moraxella-dependent alpha 1-antichymotrypsin neutralization: a unique virulence mechanism. Am J Respir Cell Mol Biol (2007) 0.79
Genome sequence of Moraxella catarrhalis RH4, an isolate of seroresistant lineage. J Bacteriol (2012) 0.79
A descriptive study of bacterial load of full-thickness surgical wounds in dermatologic surgery. Dermatol Surg (2011) 0.78
Collagen VI Is Upregulated in COPD and Serves Both as an Adhesive Target and a Bactericidal Barrier for Moraxella catarrhalis. J Innate Immun (2015) 0.78
The IgD CH1 region contains the binding site for the human respiratory pathogen Moraxella catarrhalis IgD-binding protein MID. Eur J Immunol (2006) 0.77
Crystallization and X-ray diffraction analysis of a novel surface-adhesin protein: protein E from Haemophilus influenzae. Acta Crystallogr Sect F Struct Biol Cryst Commun (2012) 0.77
Risk factors for pneumococcal carriage in day care centers: a retrospective study during a 10-year period. Pediatr Infect Dis J (2014) 0.77